Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avalo Therapeutics (AVTX) Tax Rate (2017 - 2025)

Avalo Therapeutics (AVTX) has disclosed Tax Rate for 9 consecutive years, with 0.04% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Tax Rate rose 2.0% year-over-year to 0.04%, compared with a TTM value of 0.15% through Sep 2025, down 26.0%, and an annual FY2024 reading of 0.33%, down 28.0% over the prior year.
  • Tax Rate was 0.04% for Q3 2025 at Avalo Therapeutics, up from 0.08% in the prior quarter.
  • Across five years, Tax Rate topped out at 1.15% in Q2 2021 and bottomed at 0.32% in Q4 2024.
  • Average Tax Rate over 5 years is 0.04%, with a median of 0.04% recorded in 2022.
  • The sharpest move saw Tax Rate tumbled -909bps in 2021, then soared 67bps in 2022.
  • Year by year, Tax Rate stood at 0.08% in 2021, then crashed by -198bps to 0.08% in 2022, then skyrocketed by 235bps to 0.11% in 2023, then plummeted by -394bps to 0.32% in 2024, then skyrocketed by 89bps to 0.04% in 2025.
  • Business Quant data shows Tax Rate for AVTX at 0.04% in Q3 2025, 0.08% in Q2 2025, and 0.06% in Q1 2025.